Cargando…

Ruthenium Complexes as NO Donors for Vascular Relaxation Induction

Nitric oxide (NO) donors are substances that can release NO. Vascular relaxation induction is among the several functions of NO, and the administration of NO donors is a pharmacological alternative to treat hypertension. This review will focus on the physicochemical description of ruthenium-derived...

Descripción completa

Detalles Bibliográficos
Autores principales:	Galvão de Lima, Renata, Rodrigues Silva, Bruno, Santana da Silva, Roberto, Maria Bendhack, Lusiane
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2014
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6271244/ https://www.ncbi.nlm.nih.gov/pubmed/25004072 http://dx.doi.org/10.3390/molecules19079628

Ejemplares similares

Vascular Relaxation Induced by C-Type Natriuretic Peptide Involves the Ca(2+)/NO-Synthase/NO Pathway
por: Andrade, Fernanda A., et al.
Publicado: (2014)

Contribution of oxidative stress to endothelial dysfunction in hypertension
por: Silva, Bruno R., et al.
Publicado: (2012)

The Role of Glycocalyx and Caveolae in Vascular Homeostasis and Diseases
por: Potje, Simone Regina, et al.
Publicado: (2021)

Ruthenium Complex Improves the Endothelial Function in Aortic Rings From Hypertensive Rats
por: Vatanabe, Izabela Pereira, et al.
Publicado: (2017)

Ruthenium Complex with Benznidazole and Nitric Oxide as a New Candidate for the Treatment of Chagas Disease
por: Sesti-Costa, Renata, et al.
Publicado: (2014)

NO Exchange for a Water Molecule Favorably Changes Iontophoretic Release of Ruthenium Complexes to the Skin
por: de Santana, Danielle C. A. S., et al.
Publicado: (2017)

Deficient Regulatory T Cell Activity and Low Frequency of IL-17-Producing T Cells Correlate with the Extent of Cardiomyopathy in Human Chagas' Disease
por: Guedes, Paulo Marcos Matta, et al.
Publicado: (2012)

A ruthenium-based 5-fluorouracil complex with enhanced cytotoxicity and apoptosis induction action in HCT116 cells
por: Silva, Valdenizia Rodrigues, et al.
Publicado: (2018)

C-Type Natriuretic Peptide Induces Anti-contractile Effect Dependent on Nitric Oxide, Oxidative Stress, and NPR-B Activation in Sepsis
por: Pernomian, Laena, et al.
Publicado: (2016)

Central Administration of Angiotensin-(1-7) Improves Vasopressin Impairment and Hypotensive Response in Experimental Endotoxemia
por: Passaglia, Patrícia, et al.
Publicado: (2021)

Editorial of Special Issue Ruthenium Complex: The Expanding Chemistry of the Ruthenium Complexes
por: Dragutan, Ileana, et al.
Publicado: (2015)

Reduced caveolae density in arteries of SHR contributes to endothelial dysfunction and ROS production
por: Potje, Simone R., et al.
Publicado: (2019)

Matrix metalloproteinase-2-induced epidermal growth factor receptor transactivation impairs redox balance in vascular smooth muscle cells and facilitates vascular contraction
por: Prado, Alejandro F., et al.
Publicado: (2018)

Iridium and Ruthenium Complexes Bearing Perylene Ligands
por: Mauri, Luca, et al.
Publicado: (2022)

The Influence of Some Axial Ligands on Ruthenium–Phthalocyanine Complexes: Chemical, Photochemical, and Photobiological Properties
por: Martins, Tássia Joi, et al.
Publicado: (2021)

Special Issue on Ruthenium Complexes
por: Dragutan, Ileana, et al.
Publicado: (2017)

Photocytotoxic Activity of Ruthenium(II) Complexes with Phenanthroline-Hydrazone Ligands
por: Silva-Caldeira, Priscila Pereira, et al.
Publicado: (2021)

Ruthenium(II) Polypyridyl Complexes as FRET Donors: Structure- and Sequence-Selective DNA-Binding and Anticancer Properties
por: Elgar, Christopher E., et al.
Publicado: (2023)

The Effect of Extracellular pH Changes on Intracellular pH and Nitric Oxide Concentration in Endothelial and Smooth Muscle Cells from Rat Aorta
por: Capellini, Verena K., et al.
Publicado: (2013)

Ruthenium-Catalyzed E-Selective Alkyne Semihydrogenation with Alcohols as Hydrogen Donors
por: Ekebergh, Andreas, et al.
Publicado: (2020)

Biological Activities of Ruthenium NHC Complexes: An Update
por: Catalano, Alessia, et al.
Publicado: (2023)

New Heteroleptic Ruthenium(II) Complexes with Sulfamethoxypyridazine and Diimines as Potential Antitumor Agents
por: de Melo, Ariane C.C., et al.
Publicado: (2019)

Thiol-Activated HNO Release from a Ruthenium Antiangiogenesis Complex and HIF-1α Inhibition for Cancer Therapy
por: Silva Sousa, Eduardo Henrique, et al.
Publicado: (2016)

The induction of autophagy against mitochondria-mediated apoptosis in lung cancer cells by a ruthenium (II) imidazole complex
por: Chen, Lanmei, et al.
Publicado: (2016)

Modular synthesis, host–guest complexation and solvation-controlled relaxation of nanohoops with donor–acceptor structures
por: Deng, Han, et al.
Publicado: (2022)

Vascular Response of Ruthenium Tetraamines in Aortic Ring from Normotensive Rats
por: Conceição-Vertamatti, Ana Gabriela, et al.
Publicado: (2015)

Enantioselective Olefin Metathesis with Cyclometalated Ruthenium Complexes
por: Hartung, John, et al.
Publicado: (2014)

p-Cymene Complexes of Ruthenium(II) as Antitumor Agents
por: Pujante-Galián, María Angeles, et al.
Publicado: (2020)

Theoretical Modelling of Photoswitching of Hyperpolarisabilities in Ruthenium Complexes
por: Coe, Benjamin J, et al.
Publicado: (2013)

Inhibition of cancer cell growth by ruthenium complexes
por: Iida, Joji, et al.
Publicado: (2016)

Applications of Ruthenium Complex in Tumor Diagnosis and Therapy
por: Lin, Ke, et al.
Publicado: (2018)

Anticancer Ruthenium Complexes with HDAC Isoform Selectivity
por: Cross, Jasmine M., et al.
Publicado: (2020)

Ruthenium complexes of sterically-hindered pentaarylcyclopentadienyl ligands
por: Asato, Ryosuke, et al.
Publicado: (2021)

Synthesis, Characterization, Cytotoxic Activity, and Interactions with CT-DNA and BSA of Cationic Ruthenium(II) Complexes Containing Dppm and Quinoline Carboxylates
por: da Silva, Edinaldo N., et al.
Publicado: (2017)

Induction of Relaxation by Autonomous Sensory Meridian Response
por: Sakurai, Noriko, et al.
Publicado: (2021)

A Nanostructured Lipid System to Improve the Oral Bioavailability of Ruthenium(II) Complexes for the Treatment of Infections Caused by Mycobacterium tuberculosis
por: da Silva, Patricia B., et al.
Publicado: (2018)

Novel piplartine-containing ruthenium complexes: synthesis, cell growth inhibition, apoptosis induction and ROS production on HCT116 cells
por: D’Sousa Costa, Cinara O., et al.
Publicado: (2017)

Binding of Antitumor Ruthenium(III) Complexes to Plasma Proteins
por: Messori, L., et al.
Publicado: (2000)

Synthesis and Characterization of Novel Ruthenium(III) Complexes with Histamine
por: Kljun, Jakob, et al.
Publicado: (2010)

Organometallic cis-Dichlorido Ruthenium(II) Ammine Complexes
por: Betanzos-Lara, Soledad, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_kad57km8uj9pkfhginn3di1gqi